Advances in gut microbiota in the pathogenesis and treatment of inflammatory bowel disease

doi:10.3969/j.issn.1674-8115.2022.03.015

Abstract

Abstract:

The gut microbiota plays a critical role in human health. Inflammatory bowel disease (IBD) is an immunological disease caused by various environmental factors, including the gut microbiota, in genetically susceptible individuals. Although most studies have indicated the role of gut microbiota and their metabolites in contribution to the occurrence and development of intestinal diseases by inducing inflammation and immune disorders. However, the causal relationship between microbiota and IBD pathogenesis cannot be determined. In this review, the alteration of bacterial, fungal and viral microbiota and the potential functional pathways during IBD pathogenesis are summarized. Besides, the current therapeutic approaches targeting microbiota and the promising perspectives are introduced.

Key words: inflammatory bowel disease (IBD), dysbiosis, microbiota, fungus

CLC Number:

R574.4

LI Bowen, LIU Ningning, WANG Hui. Advances in gut microbiota in the pathogenesis and treatment of inflammatory bowel disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 364-368.

TrendMD

References 40

1	GILBERT J A, BLASER M J, CAPORASO J G, et al. Current understanding of the human microbiome[J]. Nat Med, 2018, 24(4): 392-400.
2	NG S C, KAPLAN G G, TANG W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific[J]. Am J Gastroenterol, 2019, 114(1): 107-115.
3	GUAN Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease[J]. J Immunol Res, 2019, 2019: 7247238.
4	PARK J, CHEON J H. Incidence and prevalence of inflammatory bowel disease across Asia[J]. Yonsei Med J, 2021, 62(2): 99-108.
5	LLOYD-PRICE J, ARZE C, ANANTHAKRISHNAN A N, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases[J]. Nature, 2019, 569(7758): 655-662.
6	HUGHES E R, WINTER M G, DUERKOP B A, et al. Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated dysbiosis[J]. Cell Host Microbe, 2017, 21(2): 208-219.
7	KEITA ÅV, ALKAISSI L Y, HOLM E B, et al. Enhanced E. coli LF82 translocation through the follicle-associated epithelium in Crohn's disease is dependent on long polar fimbriae and CEACAM6 expression, and increases paracellular permeability[J]. J Crohns Colitis, 2019, 14(2): 216-229.
8	PALMELA C, CHEVARIN C, XU Z, et al. Adherent-invasive Escherichia coli in inflammatory bowel disease[J]. Gut, 2018, 67(3): 574-587.
9	ALAM M T, AMOS G C A, MURPHY A R J, et al. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels[J]. Gut Pathog, 2020, 12: 1.
10	ISOBE J, MAEDA S, OBATA Y, et al. Commensal-bacteria-derived butyrate promotes the T-cell-independent IgA response in the colon[J]. Int Immunol, 2019, 32(4): 243-258.
11	GLASSNER K L, ABRAHAM B P, QUIGLEY E M M. The microbiome and inflammatory bowel disease[J]. J Allergy Clin Immunol, 2020, 145(1): 16-27.
12	LEYLABADLO H E, GHOTASLOU R, FEIZABADI M M, et al. The critical role of Faecalibacterium prausnitzii in human health: an overview[J]. Microb Pathog, 2020, 149: 104344.
13	ZHOU Y, XU H, XU J, et al. F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis[J]. AMB Express, 2021, 11(1): 33.
14	QUÉVRAIN E, MAUBERT MA, MICHON C, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease[J]. Gut, 2016, 65(3): 415-425.
15	ELSON C O, CONG Y. Host-microbiota interactions in inflammatory bowel disease[J]. Gut Microbes, 2012, 3(4): 332-344.
16	VICH VILA A, IMHANN F, COLLIJ V, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome[J]. Sci Transl Med, 2018, 10(472): eaap8914.
17	LUO W, SHEN Z, DENG M, et al. Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response[J]. Mol Med Rep, 2019, 20(2): 1007-1016.
18	HENKE M T, KENNY D J, CASSILLY C D, et al. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide[J]. PNAS, 2019, 116(26): 12672-12677.
19	DAI Z, ZHANG J, WU Q, et al. The role of microbiota in the development of colorectal cancer[J]. Int J Cancer, 2019, 145(8): 2032-2041.
20	BLANDFORD L E, JOHNSTON E L, SANDERSON J D, et al. Promoter orientation of the immunomodulatory Bacteroides fragilis capsular polysaccharide A (PSA) is off in individuals with inflammatory bowel disease (IBD)[J]. Gut Microbes, 2019, 10(5): 569-577.
21	LOPEZ-SILES M, ENRICH-CAPÓ N, ALDEGUER X, et al. Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects[J]. Front Cell Infect Microbiol, 2018, 8: 281.
22	ZHANG T, JI X, LU G, et al. The potential of Akkermansia muciniphila in inflammatory bowel disease[J]. Appl Microbiol Biotechnol, 2021, 105(14/15): 5785-5794.
23	SOKOL H, LEDUCQ V, ASCHARD H, et al. Fungal microbiota dysbiosis in IBD[J]. Gut, 2017, 66(6): 1039-1048.
24	LIMON J J, SKALSKI J H, UNDERHILL D M. Commensal fungi in health and disease[J]. Cell Host Microbe, 2017, 22(2): 156-165.
25	Bojang E, Ghuman H, Kumwenda P, et al. Immune sensing of Candida albicans[J]. J Fungi (Basel), 2021, 7(2): 1-16.
26	HOARAU G, MUKHERJEE PK, GOWER-ROUSSEAU C, et al. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease[J]. mBio, 2016, 7(5): e01250-16.
27	TANG C, KAMIYA T, LIU Y, et al. Inhibition of dectin-1 signaling ameliorates colitis by inducing Lactobacillus-mediated regulatory T cell expansion in the intestine[J]. Cell Host Microbe, 2015, 18(2): 183-197.
28	LIGUORI G, LAMAS B, RICHARD M L, et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients[J]. J Crohns Colitis, 2015, 10(3): 296-305.
29	SIVIGNON A, DE VALLÉE A, BARNICH N, et al. Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease[J]. Inflamm Bowel Dis, 2015, 21(2): 276-286.
30	CHIARO TR, SOTO R, ZAC STEPHENS W, et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice[J]. Sci Transl Med, 2017, 9(380): eaaf9044.
31	LIMON J J, TANG J, LI D, et al. Malassezia is associated with Crohn's disease and exacerbates colitis in mouse models[J]. Cell Host Microbe, 2019, 25(3): 377-388.e6.
32	TARRIS G, DE ROUGEMONT A, CHARKAOUI M, et al. Enteric viruses and inflammatory bowel disease[J]. Viruses, 2021, 13(1): 104.
33	GOGOKHIA L, BUHRKE K, BELL R, et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis[J]. Cell Host Microbe, 2019, 25(2): 285-299.e8.
34	LAM S, ZUO T, HO M, et al. Review article: fungal alterations in inflammatory bowel diseases[J]. Aliment Pharmacol Ther, 2019, 50(11/12): 1159-1171.
35	MILAJERDI A, EBRAHIMI-DARYANI N, DIELEMAN L A, et al. Association of dietary fiber, fruit, and vegetable consumption with risk of inflammatory bowel disease: a systematic review and meta-analysis[J]. Adv Nutr, 2020, 12(3): 735-743.
36	AKRAM W, GARUD N, JOSHI R. Role of inulin as prebiotics on inflammatory bowel disease[J]. Drug Discov Ther, 2019, 13(1): 1-8.
37	DIEDEREN K, LI J V, DONACHIE G E, et al. Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease[J]. Sci Rep, 2020, 10(1): 18879.
38	NICHOLSON M R, MITCHELL P D, ALEXANDER E, et al. Efficacy of fecal microbiota transplantation for Clostridium difficile infection in children[J]. Clin Gastroenterol Hepatol, 2020, 18(3): 612-619.e1.
39	BURRELLO C, GARAVAGLIA F, CRIBIÙ F M, et al. Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells[J]. Nat Commun, 2018, 9(1): 5184.
40	JAKUBCZYK D, LESZCZYŃSKA K, GÓRSKA S. The effectiveness of probiotics in the treatment of inflammatory bowel disease (IBD): a critical review[J]. Nutrients, 2020, 12(7): 1973.

[1]	WANG Zhiqi, WANG Ying. Advances in the diagnosis and treatment of inflammatory bowel disease-associated anemia in children [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1232-1238.
[2]	LIANG Mengchen, LI Jiaqi, WU Xinyi, MO Xiaohui, JU Qiang. Analysis of hair follicle microbiota in non-lesional areas of patients with moderate-to-severe acne vulgaris: a single-center cross-sectional study [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(9): 1094-1103.
[3]	XIA Xixi, DING Keke, ZHANG Huiheng, PENG Xufei, SUN Yimin, TANG Yajun, TANG Xiaofang. Research progress of the role of intestinal microbiota-mediated bile acids in inflammatory bowel disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(7): 839-846.
[4]	DU Yage, LU Yanhui, AN Yu, SONG Ying, ZHENG Jie. Research progress in mechanisms of gut microbiota in diabetic cognitive impairment and its targeted intervention [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(4): 494-500.
[5]	MA Jinqian, FAN Pianpian, ZHENG Tao, ZHANG Lin, CHEN Yuanzhi, SHEN Jian, OUYANG Fengxiu. Relationship among maternal gut, vaginal microbiota and microbiota in meconium and vernix caseosa in newborns [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(1): 50-63.
[6]	LI Junru, OUYANG Yan, XIE Jingyuan. Research progress in the role of gut microbiota in the pathogenesis and treatment of IgA nephropathy [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(8): 1044-1048.
[7]	GAO Yu, YIN Shan, PANG Yue, LIANG Wenyi, LIU Yumin. Effect of rhubarb on gut microbiota-host co-metabolism in rats [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(8): 997-1007.
[8]	WEN Yajin, HE Wen, HAN Xiao, ZHANG Xiaobo. Exploratory analysis of gut microbiota differences in childhood asthma with different severity [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(6): 655-664.
[9]	WANG Jieyi, ZHENG Dan, ZHENG Xiaojiao, JIA Wei, ZHAO Aihua. Research progress in biological activities and mechanisms of theabrownin [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(6): 768-774.
[10]	LI Lu, LI Yulin, LIU Yan, DUAN Shengzhong. Periodontitis aggravates transverse aortic constriction-induced cardiac hypertrophy in mice [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(9): 1275-1287.
[11]	WANG Jie, WU Hui, LU Lingpeng, YANG Kefeng, ZHU Jie, ZHOU Hengyi, YAO Die, GAO Ya, FENG Yuting, LIU Yuhong, JIA Jie. Dynamic changes in gut microbiota of women with gestational diabetes mellitus and the correlation with blood glucose, blood lipid and diet [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(9): 1336-1346.
[12]	LU Yu, WANG Hao, BA Qian. Role of gut microbiota in hepatocellular carcinoma: cancer occurrence, progresses and treatments [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 939-944.
[13]	NURXAT Nadira, LI Min, LIU Qian. Progress in the correlation between atopic dermatitis and colonization of Staphylococcus [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(11): 1605-1611.
[14]	JIANG Yi, JIANG Ping, ZHANG Mingming, FANG Jingyuan. Research progress in the role of Akkermansia muciniphila in gut-related diseases [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(10): 1490-1497.
[15]	Ying-dan ZHANG, Zhen WANG. Research progress of the role of gut microbiota in the pathogenesis and treatment of obsessive-compulsive disorder [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 967-971.